$58.5B revenue (2025), New York-based Pfizer manufactures vaccines, oncology, and primary care drugs across 125+ countries. Strategy chief Andrew Baum departed in April 2026 amid portfolio optimization; company eyes Hong Kong expansion as part of Asia growth strategy.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.